Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY32.71 CNY
Change Today -3.63 / -9.99%
Volume 13.4M
002107 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

shandong wohua pharmaceuti-a (002107) Snapshot

Open
CNY36.18
Previous Close
CNY36.34
Day High
CNY36.19
Day Low
CNY32.71
52 Week High
05/25/15 - CNY51.41
52 Week Low
07/28/14 - CNY5.84
Market Cap
11.8B
Average Volume 10 Days
13.3M
EPS TTM
CNY0.19
Shares Outstanding
360.8M
EX-Date
03/19/15
P/E TM
175.5x
Dividend
CNY0.10
Dividend Yield
0.38%
Current Stock Chart for SHANDONG WOHUA PHARMACEUTI-A (002107)

Related News

No related news articles were found.

shandong wohua pharmaceuti-a (002107) Related Businessweek News

No Related Businessweek News Found

shandong wohua pharmaceuti-a (002107) Details

Shandong Wohua Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese traditional patent medicines for the treatment of cardiovascular and cerebrovascular disease in China. The company offers tablets, hard capsules, granules, pills, powders, oral solutions, mixtures, alcoholature, soft extracts, syrup, dripping pills, extracorporeal diagnostic reagents, and others for cardiovascular, respiratory, women and children’s medication, urinary system, heat purging fire, digestive, antirheumatic drugs, and tonic sedative class diseases. Its primary products include Xinkeshu tablets and capsules for the treatment of coronary heart disease; Naoxueshu oral liquid, which promotes blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus; and Yuandu granules for the treatment of influenza. Shandong Wohua Pharmaceutical Co., Ltd. is based in Weifang, China.

shandong wohua pharmaceuti-a (002107) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shandong wohua pharmaceuti-a (002107) Key Developments

Shandong Wohua Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Jul 06, 2015

Shandong Wohua Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Jul 06, 2015

Shandong Wohua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jun 08, 2015

Shandong Wohua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jun 08, 2015., at 14:00 China Standard Time. Agenda: To consider connected transaction regarding change of the implementing method for some projects invested by raised funds to acquire relevant assets.

Shandong Wohua Pharmaceutical Co., Ltd. Approves Dividend for 2014; Approves Amendments to Articles of Association

Shandong Wohua Pharmaceutical Co., Ltd. approved cash dividend/10 shares (tax included) of CNY 3.50000000 for 2014 at the Annual General Meeting held on 20 May 2015. At the meeting, the company also approved amendments to the articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002107:CH CNY32.71 CNY -3.63

002107 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002107.
View Industry Companies
 

Industry Analysis

002107

Industry Average

Valuation 002107 Industry Range
Price/Earnings 100.0x
Price/Sales 42.2x
Price/Book 22.4x
Price/Cash Flow 248.0x
TEV/Sales 38.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG WOHUA PHARMACEUTI-A, please visit www.wohua.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.